6620.TWO

Handa Pharmaceuticals, Inc.

HealthcareDrug Manufacturers - Specialty & GenericTWTWDPeers →via fmp_bulkCountry macro →

$72.20

+6.18%LiveJun 15, 2026

Market cap

$11.87B

52w range

—

P / E

—

EPS

—

Volume

—

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Handa Pharmaceuticals, Inc.’s valuation

Enterprise value

$10.9B

Market cap

$11.87B

Net debt

—

Total debt

—

Cash & ST inv.

—

Capital structure

· balance sheet · 2026-06-16

Market capitalisation$11.87B

+ Total debt+—

− Cash & short-term investments−—

= Enterprise value$10.9B

Valuation

· key metrics · TTM

EV / EBITDA—

EV / Sales7.4×

EV / FCF27.1×

Net debt / EBITDA-1.2×

Debt / Equity—

Arphra AIPlain-English read on the EV build & leverage